Government of Zambia provides incentives for pharma industry

4 July 2011

The Zambian government last week introduced incentives aimed at protecting the local steel-iron and pharmaceutical manufacturing industries, including preferential government procurement for local drugmakers with the aim of making them more cometitive, with immediate effect, reports the local Post Online.

Announcing the measures at the 47th Zambia International Trade Fair in Ndola, President Rupiah Banda said there is need for all business houses in the country to work together with government and ensure that Zambian goods are competitive in both quality and pricing.

Speaking when he officially opened this year’s Zambia International Trade Fair, President Banda said government was aware of the challenges faced by the private sector that have constrained innovation and competitiveness.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics